| Website | infraredx.com |
| Category | BioTech |
| Phone | 781-221-0053 |
| Employees | |
| Founded | 1998 |
| Total | $65.1M |
| Unattributed, 1/10 | $10M |
| Series D, 10/10 Sanderling Ventures | $21M |
| Unattributed, 6/11 | $24.1M |
| Debt, 12/11 GE Capital | $10M |
InfraReDx, Inc. designs, develops, manufactures, and distributes medical devices. The company specializes in near-infrared spectroscopic (NIRS) technology and its application to coronary imaging. It develops a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. The company was founded in 1998 and is headquartered in Burlington, Massachusetts.